By Daniel Levine
“The pharmaceutical industry has long argued that high drug prices are necessary to incentivize investment in and fund high-risk research and development of innovative new therapies.”…
[Click HERE to listen the interview]
By Daniel Levine
“The pharmaceutical industry has long argued that high drug prices are necessary to incentivize investment in and fund high-risk research and development of innovative new therapies.”…
[Click HERE to listen the interview]